139 related articles for article (PubMed ID: 15322162)
1. Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection.
Kreisel D; Krasinskas AM; Krupnick AS; Gelman AE; Balsara KR; Popma SH; Riha M; Rosengard AM; Turka LA; Rosengard BR
J Immunol; 2004 Sep; 173(5):3027-34. PubMed ID: 15322162
[TBL] [Abstract][Full Text] [Related]
2. A two-step model of acute CD4 T-cell mediated cardiac allograft rejection.
Grazia TJ; Pietra BA; Johnson ZA; Kelly BP; Plenter RJ; Gill RG
J Immunol; 2004 Jun; 172(12):7451-8. PubMed ID: 15187123
[TBL] [Abstract][Full Text] [Related]
3. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
[TBL] [Abstract][Full Text] [Related]
4. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection.
Krasinskas AM; Eiref SD; McLean AD; Kreisel D; Gelman AE; Popma SH; Moore JS; Rosengard BR
Transplantation; 2000 Aug; 70(3):514-21. PubMed ID: 10949196
[TBL] [Abstract][Full Text] [Related]
5. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
6. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
[TBL] [Abstract][Full Text] [Related]
7. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells.
Tanaka K; Sonoda K; Streilein JW
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532
[TBL] [Abstract][Full Text] [Related]
8. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
9. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells.
Hasegawa S; Becker G; Nagano H; Libby P; Mitchell RN
Am J Pathol; 1998 Jul; 153(1):69-79. PubMed ID: 9665467
[TBL] [Abstract][Full Text] [Related]
10. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG
Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954
[TBL] [Abstract][Full Text] [Related]
11. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
12. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition.
Kreisel D; Krupnick AS; Gelman AE; Engels FH; Popma SH; Krasinskas AM; Balsara KR; Szeto WY; Turka LA; Rosengard BR
Nat Med; 2002 Mar; 8(3):233-9. PubMed ID: 11875493
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
Buonocore S; Flamand V; Goldman M; Braun MY
Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
[TBL] [Abstract][Full Text] [Related]
14. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation.
Boisgérault F; Liu Y; Anosova N; Ehrlich E; Dana MR; Benichou G
J Immunol; 2001 Aug; 167(4):1891-9. PubMed ID: 11489968
[TBL] [Abstract][Full Text] [Related]
15. Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion.
Kreisel D; Krupnick AS; Balsara KR; Riha M; Gelman AE; Popma SH; Szeto WY; Turka LA; Rosengard BR
J Immunol; 2002 Dec; 169(11):6154-61. PubMed ID: 12444119
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cells as antigen-presenting cells: role in human transplant rejection.
Rose ML
Cell Mol Life Sci; 1998 Sep; 54(9):965-78. PubMed ID: 9791539
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
[TBL] [Abstract][Full Text] [Related]
18. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection.
Forbes RD; Parfrey NA; Gomersall M; Darden AG; Guttmann RD
J Exp Med; 1986 Oct; 164(4):1239-58. PubMed ID: 3531383
[TBL] [Abstract][Full Text] [Related]
20. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.
Auchincloss H; Lee R; Shea S; Markowitz JS; Grusby MJ; Glimcher LH
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3373-7. PubMed ID: 8475083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
